Navigation Links
ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
Date:4/30/2008

006, ISTA licensed from Senju the exclusive North American rights to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release related to bringing a new product to market every 12 to 18 months, completing the preliminary analysis of the data from the Bepreve ocular safety study in the second quarter of 2008, filing the Bepreve NDA with the FDA in the second half of 2008, and becoming the leading niche ophthalmic pharmaceutical company are forward-looking statements. Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements. These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ from current expectations include, among others: timely and successful implementat
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
2. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
3. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
6. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
9. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014  Decision Resources Group,s new Manhattan ... that online information and other value-added services ... their offering and support physicians. Physicians who ... rely on websites, mobile apps and other ... physicians are looking to manufacturers to provide ...
(Date:9/15/2014)... , Sept. 15, 2014 myMatrixx has extended ... Stanos with an expanded role that includes direct ... Dr. Stanos, a nationally recognized physiatrist and pain management ... to rehabilitation and workers, compensation, is Board Certified in ... American Board of Pain Medicine and subspecialty boarded by ...
(Date:9/15/2014)... Sept. 15, 2014  Catalist-listed QT Vascular Ltd. ("QT ... developer and manufacturer of minimally invasive medical devices for ... that the Group has enrolled the first European patients ... . Multiple patients have already been enrolled in this ... City Hospital, in Auckland, New Zealand ...
Breaking Medicine Technology:Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO 2First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5
... , SACRAMENTO, Calif., Nov. 10 The Joint ... Ventricular Assist Device/Destination Therapy certification, allowing the Sacramento ... ventricular assist devices (LVADs) as permanent therapy and ... Medical Center, Sacramento is the only hospital in ...
... Stryker Corporation (NYSE: SYK ) announced today that ... technology firm. OtisMed will focus on customizable instrumentation ... that surgeons and patients realize from Stryker,s Triathlon Knee ... operate as part of Stryker,s Orthopaedics Division and remain ...
Cached Medicine Technology:Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy 2Stryker Announces Agreements To Acquire Assets 2Stryker Announces Agreements To Acquire Assets 3
(Date:9/15/2014)... 2014 Octo Consulting Group, a ... to the federal government, today announced it is ... Atlanta, Georgia to better serve existing and future ... is credited to the strong growth momentum of ... of management consulting, agile software development, data visualization, ...
(Date:9/15/2014)... By Randy Dotinga ... (HealthDay News) -- Patients prescribed cholesterol-lowering drugs are more ... if the medications are cheaper generic brands, new research ... as statins. Well-known brands include Crestor, Zocor and Lipitor. ... to lower the risk of heart problems due to ...
(Date:9/15/2014)... approximately one out of every 40 individuals in the United ... muscular atrophy (SMA), a neurodegenerative disease that causes muscles to ... have made a recent breakthrough with the development of a ... of the disease. In April, a patent was filed for ... lab is using to fight SMA is to ,repress the ...
(Date:9/15/2014)... Texas (PRWEB) September 16, 2014 ... key market data on the Canada Gynecological Devices ... US dollars, volume (in units) and average prices ... Female Sterilization Devices (Transcervical Sterilization ... and Rings) , Endometrial Ablation Devices ...
(Date:9/15/2014)... September 15, 2014 In order to ... medicine often act conjointly to quantify, define and model ... become an integral part of medical care. , The ... the studies conducted by the non-profit Institute of BioAcoustic ... demonstrated that math can be much more than a ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3
... Video game makers are now looking to extend their reach beyond ... a really ripe market awaits them. For the aging population in ... water.// ,Leading games manufacturer, Nintendo has sold 3.3 million ... May last. "We wanted to reach out to those who were ...
... uses the construction abilities of tiny viruses to build ... batteries.// , MIT Professors Angela Belcher, Paula ... few genes within common laboratory virus strains were able ... functional electronic device. ,Batteries are made of ...
... Emirates are concerned with the proposal of the Ministry of ... the country.// ,"A committee has been set up ... provides for the private medical sector. This includes the licensing ... and the licensing of the medical or health establishments as ...
... Pink is angry that teenage girls are so obsessed with ... a sex tape.// ,According to contactmusic.com, Pink caused controversy ... in her song "Stupid Girls". But she says there is ... the popularity of Hilton's raunchy homemade film made with her ...
... Association, Les Woolard of Moree says that the Federal Government ... prepared to work in regional areas. // ,According to ... who live in Newcastle, Sydney and Wollongong there are six ... there is only one psychologist. ,He said that ...
... obesity is that the amount of junk food youngsters ... spend// watching television. Researchers analyzed the dietary and viewing habits ... , It was found that consumption of sweets and fizzy ... the idiot box. Researchers at the universities of Aberdeen and ...
Cached Medicine News:Health News:TV Viewing Increases Intake of Junk Food 2
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: